Guangdong, China

John J Talley



Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: John J Talley: Innovator in Pharmaceutical Chemistry

Introduction

John J Talley is a prominent inventor based in Guangdong, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for cancer treatment. With a total of 2 patents, his work showcases innovative approaches to addressing critical health challenges.

Latest Patents

One of Talley's latest patents focuses on azaaromatic amide derivatives for the treatment of cancer. This application details a preparation method and the use of these derivatives, which can regulate certain mutant forms of epidermal growth factor receptors. The compounds or their pharmaceutically acceptable salts are designed to treat or prevent diseases mediated by EGFR, HER2, or HER4. Another notable patent involves a 4-sulfur pentafluoride phenol compound and its preparation method. This invention simplifies the synthesis of sulfur pentafluoride substituted benzopyran compounds, offering a cost-effective solution with wide industrial application prospects.

Career Highlights

Throughout his career, John J Talley has worked with notable organizations such as Shenzhen Forward Pharmaceuticals Co., Ltd. and the Chinese Academy of Sciences. His experience in these institutions has allowed him to refine his expertise in pharmaceutical research and development.

Collaborations

Talley has collaborated with esteemed colleagues, including Chenggang Zhu and Xuan Yang. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

John J Talley's innovative work in pharmaceutical chemistry, particularly in cancer treatment, highlights his significant contributions to the field. His patents reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…